An Extension Study for Patients Previously Treated With ARQ 501
To provide ongoing treatment with ARQ 501 for patients who have benefited from prior treatment with ARQ 501
Cancer
DRUG: ARQ 501
To provide ongoing treatment with ARQ 501 for patients who have benefited from prior treatment with ARQ 501, No time frame
To collect additional safety and tolerability information for ARQ 501 treatment, No time frame
To provide ongoing treatment with ARQ 501 for patients who have benefited from prior treatment with ARQ 501